Department of Neuroscience, University of Sassari, Italy.
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):482-90. doi: 10.2174/187152710791556177.
The classical animal models of Parkinson's disease (PD) rely on the use of neurotoxins, including 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine and, more recently, the agricultural chemicals paraquat and rotenone, to deplete dopamine (DA). These neurotoxins elicit motor deficits in different animal species although MPTP fails to induce a significant dopaminergic neurodegeneration in rats. In the attempt to better reproduce the key features of PD, in particular the progressive nature of neurodegeneration, alternative PD models have been developed, based on the genetic and neuropathological links between -synuclein ( -syn) and PD. In vivo microdialysis was used to investigate extracellular striatal DA dynamics in MPTP- and -syn-generated rodent models of PD. Acute and sub-acute MPTP intoxication of mice both induce prolonged release of striatal DA. Such DA release may be considered the first step in MPTP-induced striatal DA depletion and nigral neuron death, mainly through reactive oxygen species generation. Although MPTP induces DA reduction, neurochemical and motor recovery starts immediately after the end of treatment, suggesting that compensatory mechanisms are activated. Thus, the MPTP mouse model of PD may be unsuitable for closely reproducing the features of the human disease and predicting potential long-term therapeutic effects, in terms of both striatal extracellular DA and behavioral outcome. In contrast, the -syn-generated rat model of PD does not suffer from a massive release of striatal DA during induction of the nigral lesion, but rather is characterized by a prolonged reduction in baseline DA and nicotine-induced increases in dialysate DA levels. These results are suggestive of a stable nigrostriatal lesion with a lack of dopaminergic neurochemical recovery. The -syn rat model thus reproduces the initial stage and slow development of PD, with a time-dependent impairment in motor function. This article will describe the above experimental PD models and demonstrate the utility of microdialysis for their characterization.
帕金森病 (PD) 的经典动物模型依赖于神经毒素的使用,包括 1-甲基-4-苯基-1,2,3,6-四氢吡啶 (MPTP)、6-羟多巴胺和最近的农业化学品百草枯和鱼藤酮,以耗尽多巴胺 (DA)。这些神经毒素在不同的动物物种中引起运动缺陷,尽管 MPTP 未能在大鼠中引起明显的多巴胺能神经退行性变。为了更好地再现 PD 的关键特征,特别是神经退行性变的进行性,已经开发了替代 PD 模型,这些模型基于 -突触核蛋白 ( -syn) 和 PD 之间的遗传和神经病理学联系。体内微透析用于研究 MPTP 和 -syn 产生的 PD 啮齿动物模型中纹状体 DA 的细胞外动力学。急性和亚急性 MPTP 中毒均可诱导纹状体 DA 的延长释放。这种 DA 释放可被视为 MPTP 诱导的纹状体 DA 耗竭和黑质神经元死亡的第一步,主要通过活性氧的产生。尽管 MPTP 诱导 DA 减少,但神经化学和运动恢复在治疗结束后立即开始,表明激活了代偿机制。因此,MPTP 诱导的 PD 小鼠模型可能不适合紧密再现人类疾病的特征,也不适合预测潜在的长期治疗效果,无论是从纹状体细胞外 DA 还是行为结果来看。相比之下,-syn 诱导的 PD 大鼠模型在诱导黑质损伤期间不会经历纹状体 DA 的大量释放,而是表现为基线 DA 的延长减少和尼古丁诱导的透析液 DA 水平增加。这些结果表明存在稳定的黑质纹状体病变,缺乏多巴胺能神经化学恢复。-syn 大鼠模型因此再现了 PD 的初始阶段和缓慢发展,伴有运动功能的时间依赖性损害。本文将描述上述实验性 PD 模型,并展示微透析在其特征描述中的应用。